Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab. Brooks TR, Zabor EC, Bedelu Y, Yang X MD, et al. Blood 2025 Jul 15:blood.2025029117. doi: 10.1182/blood.2025029117.

Read + Share

Amedeo Smart

Independent Medical Education

Brooks TR, Zabor EC, Bedelu Y, Yang X MD, et al. Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab. Blood 2025 Jul 15:blood.2025029117. doi: 10.1182/blood.2025029117.
PMID: 40663785